The Food and Drug Administration is scheduled to review a new allergy medication for market approval. The med is a combination of the asthma drug Singulair and the allergy tablet Claritin. Drugmakers Schering-Plough and Merck are seeking approval of the combination for use by patients who have allergic rhinitis.
Read moreI'm still frequently amazed at how much the Internet shrinks the world. An author in the United Kingdom was researching her book on... Read more »
Around 2003, when Mom exhibited memory loss but hadn’t been diagnosed with Alzheimer’s, I wish that my family would have had access to... Read more »
I have a lot of friends who have a cheat day built into their eating plan. They watch what they eat six days of the week and then one day,... Read more »
While I’m not as familiar with the LA Weight Loss plan as other diets, I do know many people who have experienced success on the program.... Read more »
The NutriSystem program has changed quite a bit over the years. When I first learned of this program back in high school, they had centers... Read more »
A mother-to-be wants to know if it is safe to treat asthma symptoms with Flovent, Claritin, and albuterol while breast-feeding. International... Read more »
The U.S. Food and Drug Administration (FDA) has turned down an application for a combo allergy drug. The medication would have combined the allergy... Read more »
The experimental osteoporosis drug Fablyn (lasofoxifene) works as well as current treatments, but not much better, a new study suggests. In a study... Read more »
Beginning this month, the 100 watt light bulb and all frosted, opaque, and pearl finished bulbs are being phased out in Great Britain. The effort... Read more »
A review of previous studies completed by the British Medical Journal and Channel 4 News in Great Britain suggests that there is no evidence that the... Read more »